Award
Delivery Order #15B10927F00000015
Delivery Order for Controlled and Non-Controlled Medications by McKesson
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$19,336.50
Ceiling
$19,336.50
Awarded
November 01, 2026
Period of Performance
Nov 01, 2026 – Nov 30, 2026
Identifier
15B10927F00000015
NAICS
325412
This award represents a delivery order under a significant indefinite delivery vehicle (IDV) contract, specifically a Pharmaceutical Prime Vendor Contract (PPV) managed by McKesson Corporation. McKesson, a leading pharmaceutical distributor, is tasked with providing controlled and non-controlled medications specifically aimed at treating opioid use disorder in inmate populations through Medication-Assisted Treatment (MAT) therapy. The contract highlights its critical role in supporting healthcare programs that address substance use disorders in correctional facilities. The scope includes multiple invoices for medication purchases to be delivered over the course of one month, demonstrating an ongoing supply chain effort under the broader prime vendor agreement. This order was issued as part of a competitive prime vendor contract framework, ensuring reliable medication procurement and distribution. The period of performance is a short-term, one-month window, consistent with operational needs to maintain uninterrupted medical support. This focused delivery order exemplifies efficient contract execution within a substantial multi-year pharmaceutical supply agreement benefiting inmate healthcare and public health outcomes.
Description
MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY27 01-30 NOV